News & Events

News & Events

News

ARTHEx Biotech to Participate in the 24th Annual Needham Virtual Healthcare Conference

November 11, 2024

ARTHEx Biotech Announces Oral Presentation on ATX-01 at TIDES Europe Annual Meeting 2024

November 7, 2024

ARTHEx Biotech Announces FDA Rare Pediatric Designation (RPD) of ATX-01 for the Treatment of Myotonic Dystrophy Type 1 (DM1)

October 18, 2024

ARTHEx Biotech Announces First Patient Dosed in Phase I-IIa ArthemiR™ Trial for Myotonic Dystrophy Type 1 (DM1)

October 15, 2024

ARTHEx Biotech Announces Publication of Promising Preclinical Research for Myotonic Dystrophy Type 1 (DM1)

September 25, 2024

ARTHEx Biotech Announces Participation in 8th Annual Chardan Genetic Medicines Conference

ARTHEx Biotech Announces Participation in Barclays Biotech: 1x1 Private Company Symposium

ARTHEx Biotech Announces Oral Presentation on ATX-01 at the Oligonucleotide & Peptide Therapeutics (TIDES) Conference 2024

ARTHEx Biotech Announces Participation at the 23rd Annual Needham Virtual Healthcare Conference

Events

April 7-10, 2025

24th Annual Needham Virtual Healthcare Conference

September 30 - October 1, 2024

8th Annual Chardan Genetic Medicines Conference

Barclays Biotech: 1x1 Private Company Symposium

May 14 - 17, 2024

Oligonucleotide & Peptide Therapeutics(TIDES) Conference 2024

April 8-11, 2024

23rd Annual Needham Virtual Healthcare Conference

October 30 - November 1, 2023

Tides Europe 2023

October 26 - 27, 2023

Spanish Meeting on Oligonucleotide Therapeutics (SMOT III)

October 22-25, 2023

19th Annual Meeting of the Oligonucleotide Therapeutics Society (OTS)

September 6–7, 2023

RNA Leaders USA Congress

May 7 – 10, 2023 | San Diego, CA USA

TIDES USA - Oligonucleotide & Peptide Therapeutics

November 16-18, 2022, Vienna

October 2-5,2022, Phoenix

18th Annual Meeting of the Oligonucleotide Therapeutics Society

September 9-10, 2022; San Diego

2022 MDF Annual Conference

Bassel. September 21-22, 2022

22ND ANNUAL BIOTECH IN EUROPE FORUM

October 17-18, 2023

3rd Annual Needham Private Biotech Company Virtual 1x1 Forum